Paul E. Cayer, MBA

Paul Cayer brings more than 30 years of experience in the pharmaceutical, medical device and healthcare technology fields. Prior to joining Ashvattha, Paul served as Chief Financial and Business Officer at Otonomy, a company that specialized in developing therapeutics for diseases and disorders of the ear. There, he led the team in raising over $550 million in private and public financings and was responsible for completing multiple collaborations and asset sales. He previously served as Senior Vice President, Corporate Development for Verus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the treatment of allergic and respiratory disorders in children. Paul has also held various management positions with Targeted Molecules Corporation, a biopharmaceutical company, Gensia, Inc., a biopharmaceutical company, Acuson, a provider of medical ultrasound systems, Castle & Cooke, a consumer products company, and served as a consultant with Booz Allen & Hamilton, a management and technology consulting firm. Paul received his bachelor’s degree in biomechanical engineering from Harvard University and MBA from the Harvard Business School.